I'm slightly concerned with the medium-term effectiveness of those vaccines, since most of them target exclusively the spike protein. That's a very limited pool of antigen epitopes, some of which could likely be changed with a single base pair mutation.
The virus will be under tremendous evolutionary pressure and variants that evade neutralizing antibodies might have a chance to proliferate, though with less potency than the virus has against "virgin" immune systems.
Depending on how severe the disease still remains, especially for the vulnerable groups, booster shots might be needed. Either that or second-generation live attenuated vaccines become the gold standard for immunization.
Edit - that all is assuming cell-based immunity to the spike protein will be affected, and not counting antibody affinity maturation, which might work to prevent infection altogether no matter what. So, that might not even happen. Smallpox was flat out eradicated just by providing immunity to a different virus, after all.
Last edited by haxxiy - on 25 January 2021